Esperion Therapeutics, Inc. (0IIM.L) LSE

2.57

-0.095(-3.57%)

Updated at September 08 06:39PM

Currency In USD

Valuation

Market Cap411.8M
Enterprise Value858.25M
P/E Ratio-5.49
PEG Ratio-0.14
Price/Sales Ratio2.01
Price/Book Ratio0
Enterprise/Revenue2.24
Enterprise/EBITDA-24.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.36
Operating Margin-0.1

Management Effectiveness

Return On Assets-0.27
Return On Equity0.32

Income Statement

Revenue332.31M
Revenue/Share1.36
Gross Profit263.71M
EBITDA7.57M
Net Income-51.75M
Diluted EPS-0.28

Balance Sheet

Total Cash86.06M
Total Cash/Share0.44
Total Debt146.45M
Total Debt/Equity0
Current Ratio0
Book Value Per Share1.8

Price History

52-Week Change56.73
52-Week High3.32
52-Week Low0.71
Moving Average 50 Days2.51
Moving Average 200 Days1.67

Statistics

Average Volume26,659
Shares Outstanding196.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A